Serum core fucosylated antithrombin-iii protein detection kit
By using magnetic bead-coupled antibody and lectin LCA, the core fucosylated antithrombin-III protein can be directly detected from serum samples, solving the problem of complex protein purification in existing technologies, simplifying detection and improving accuracy, and providing a new tool for the early diagnosis of liver diseases and tumors.
Patent Information
- Application Number
- CN202610546877.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-04-23
- Publication Date
- 2026-07-17
AI Technical Summary
Existing mass spectrometry and lectin chip technologies require complex protein purification steps when detecting glycosylated antithrombin-III protein, and cannot directly use serum samples, which increases the complexity and difficulty of detection and limits their application in clinical testing.
By using magnetically bead-coupled anti-ATⅢ protein antibody and lentil lectin LCA, core fucosylated antithrombin-III protein can be directly detected from serum samples via colorimetric reaction and ELISA reader, simplifying the detection process and improving detection accuracy.
It enables precise measurement of the level of core fucosylated antithrombin-III protein in serum, simplifies the detection procedure, reduces equipment and reagent costs, facilitates implementation in clinical settings, and provides a time window for early disease diagnosis.
Smart Images
Figure CN122410047A_ABST